These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8314937)

  • 1. Determination of chloroacetaldehyde, a metabolite of oxazaphosphorine cytostatic drugs, in plasma.
    Kaijser GP; Beijnen JH; Jeunink EL; Bult A; Keizer HJ; de Kraker J; Underberg WJ
    J Chromatogr; 1993 May; 614(2):253-9. PubMed ID: 8314937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy.
    Kurowski V; Wagner T
    Cancer Chemother Pharmacol; 1993; 33(1):36-42. PubMed ID: 8269587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic-fluorescent method to determine chloroacetaldehyde, a neurotoxic metabolite of the anticancer drug ifosfamide, in plasma and in liver microsomal incubations.
    Huang Z; Waxman DJ
    Anal Biochem; 1999 Aug; 273(1):117-25. PubMed ID: 10452807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal-tubule metabolism of ifosfamide to the nephrotoxic chloroacetaldehyde: pharmacokinetic modeling for estimation of intracellular levels.
    Aleksa K; Ito S; Koren G
    J Lab Clin Med; 2004 Mar; 143(3):159-62. PubMed ID: 15007305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and pharmacokinetics of oral and intravenous ifosfamide.
    Kurowski V; Cerny T; Küpfer A; Wagner T
    J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S148-53. PubMed ID: 1795004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells.
    Zaki EL; Springate JE; Taub M
    Toxicol In Vitro; 2003 Aug; 17(4):397-402. PubMed ID: 12849722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo.
    Springate JE
    J Appl Toxicol; 1997; 17(1):75-9. PubMed ID: 9048231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.
    Springate J; Chan K; Lu H; Davies S; Taub M
    In Vitro Cell Dev Biol Anim; 1999 Jun; 35(6):314-7. PubMed ID: 10476917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of ifosfamide to chloroacetaldehyde contributes to antitumor activity in vivo.
    Börner K; Kisro J; Brüggemann SK; Hagenah W; Peters SO; Wagner T
    Drug Metab Dispos; 2000 May; 28(5):573-6. PubMed ID: 10772637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites.
    Woodland C; Ito S; Granvil CP; Wainer IW; Klein J; Koren G
    Life Sci; 2000 Nov; 68(1):109-17. PubMed ID: 11132240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide.
    Dubourg L; Michoudet C; Cochat P; Baverel G
    J Am Soc Nephrol; 2001 Aug; 12(8):1615-1623. PubMed ID: 11461933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved and simplified liquid chromatographic assay for adefovir, a novel antiviral drug, in human plasma using derivatization with chloroacetaldehyde.
    Sparidans RW; Veldkamp A; Hoetelmans RM; Beijnen JH
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):115-21. PubMed ID: 10676990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroacetaldehyde: mode of antitumor action of the ifosfamide metabolite.
    Brüggemann SK; Radike K; Braasch K; Hinrichs J; Kisro J; Hagenah W; Peters SO; Wagner T
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):349-56. PubMed ID: 16133533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication.
    Pohl J; Stekar J; Hilgard P
    Arzneimittelforschung; 1989 Jun; 39(6):704-5. PubMed ID: 2505783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivatization-liquid chromatographic assay of chloroacetaldehyde in biological samples.
    Ruzicka JA; Ruenitz PC
    J Chromatogr; 1990 Oct; 518(2):385-9. PubMed ID: 2254389
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of ifosforamide mustard, the active metabolite of ifosfamide, in plasma.
    Kaijser GP; Beijnen JH; Rozendom E; Bult A; Underberg WJ
    J Chromatogr B Biomed Appl; 1996 Nov; 686(2):249-55. PubMed ID: 8971607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of short-term use of dexamethasone on the pharmacokinetics of ifosfamide in patients.
    Brüggemann SK; Pfäffle S; Peters SO; Wagner T
    Drug Metab Dispos; 2007 Oct; 35(10):1721-4. PubMed ID: 17600085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 4-hydroxyifosfamide in biological matrices by high-performance liquid chromatography.
    Kaijser GP; Ter Riet PG; de Kraker J; Bult A; Beijnen JH; Underberg WJ
    J Pharm Biomed Anal; 1997 Mar; 15(6):773-81. PubMed ID: 9172103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The analysis of ifosfamide and its metabolites (review).
    Kaijser GP; Korst A; Beijnen JH; Bult A; Underberg WJ
    Anticancer Res; 1993; 13(5A):1311-24. PubMed ID: 8239501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrofluorimetric determination of 2-chloro-2'-deoxyadenosine (cladribine) in human plasma by photochemical reaction and chloroacetaldehyde derivatization.
    Gajewska M; Pawiński T; Dzierzgowska-Szmidt A; Kazimierczuk Z
    Pharmazie; 1995 Jul; 50(7):459-60. PubMed ID: 7675888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.